Form 4 for ELVN Enliven Therapeutics, Inc.
Accepted 2023-12-27 00:00:00 ET · period of report 2023-12-22 · accession 0001209191-23-059814 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-12-27 | 2023-12-22+ | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $15.06 | -1,130 | 0 | -100% | -$17.0K |
| DM | 2023-12-27 | 2023-12-22+ | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +1,130 | 100 | New | +$2,802 |
| DM | 2023-12-27 | 2023-12-22+ | ELVN | Hohl Benjamin | CFO | M - OptEx | $0.00 | -1,130 | 261.1K | -0.4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-22 | S | D | 1,030 | $15.07 | 0 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $15.00 to $15.24. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Common Stock | 2023-12-26 | S | D | 100 | $15.00 | 0 | D | — | — | |
| 3 | Common | Common Stock | 2023-12-22 | M | A | 1,030 | $2.48 | 1,030 | D | — | — | |
| 4 | Common | Common Stock | 2023-12-26 | M | A | 100 | $2.48 | 100 | D | — | — | |
| 5 | Derivative | Employee Stock Option (right to buy) | 2023-12-26 | M | D | 100 | $0.00 | 260,990 | D | $2.48 · — to 2031-08-02 | 100 Common Stock | (F3) The option, originally for 262,120 shares, vested as to one-fourth of the shares vests on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2023-12-22 | M | D | 1,030 | $0.00 | 261,090 | D | $2.48 · — to 2031-08-02 | 1,030 Common Stock | (F3) The option, originally for 262,120 shares, vested as to one-fourth of the shares vests on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter. |